First Biomarker Discovered That Predicts Prostate Cancer Outcome
Science Daily — Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. The report on the B7-H3 molecule by Mayo Clinic Cancer Center appears in Cancer Research. "This discovery will allow physicians to individualize treatment and [...]
